School of Medicine
Showing 241-260 of 418 Results
-
Dung Nguyen
Clinical Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Dung H Nguyen is currently the Director of Breast Reconstruction at the Stanford Women’s Cancer Center, Director of Microsurgery and Microsurgery Fellowship, and the Director of Adult Plastics Clinic at Stanford Healthcare. She graduated with a Bachelor of Science in Biochemistry and highest academic honor and distinction from U.C. Davis. She earned a Pharm.D degree from U.C.S.F. School of Pharmacy and a MD degree from U.C.S.D. She then did a residency in general surgery and a residency in Plastic and Reconstructive Surgery at the University of Southern California (USC) Medical Center. She further completed a fellowship in microsurgery from Chang Gung Memorial Hospital in Taiwan, one of the largest reconstructive surgery centers in the world. She was recruited to Stanford from Cedar Sinai Medical Center in 2012, and is currently a Clinical Professor in the Division of Plastic and Reconstructive Surgery at Stanford University.
Dr. Nguyen specializes in aesthetic and reconstructive breast surgery, surgical treatment of lymphedema including vascularized lymph node transfer and lymphaticovenous anastomosis, and complex tissue reconstruction utilizing microsurgery and supermicrosurgery. She also has interest in cosmetic surgery, including facial rejuvenation and body contouring procedures.
In addition to her clinical commitment, Dr. Nguyen has basic science and clinical research interests in lymphedema and breast reconstruction. She has published articles in peer review journals, presented at national and international professional meetings and has authored book chapters in various plastic surgery textbooks. She also enjoys volunteering on overseas medical missions and participating in medical charity activities. -
Henry Hoang Nguyen
MD Student with Scholarly Concentration in Bioengineering / Quality Improvement, expected graduation Spring 2027
BioHenry Nguyen was born and raised in Abbeville, Louisiana, and is a proud graduate of Xavier University of Louisiana. Before becoming a Stanford medical student in 2022, Henry co-founded organizations dedicated to increasing inclusivity in the fields of competitive athletics, the performing arts, and media production. Stanford’s distinct environment has allowed him to continue nurturing these organizations during medical school, and he has also picked up new projects contributing to cutting-edge innovation in the fields of biotechnology, medical education, and video game design.
Henry has taken classes at Stanford’s law school, business school, and engineering school to augment his MD education. He then applied these skills to assist multiple companies in successfully acquiring venture capital funding, and he continues to serve as a trusted advisor to major Artificial Intelligence firms, such as Synaptiq Learning, Anthropic, and Snorkel AI. Henry is the youngest person to ever be elected to the Stanford Medicine Alumni Board of Governors and has been awarded multiple Stanford-based grants to support his scholarly activity in neuroimaging. Lastly, he has actively supported the Stanford Medicine Radiology Department by reviving the Radiology Interest Group, leading pre-clinical radiology electives, and designing a completely new radiology clerkship.
Henry hopes to follow the example of his mentors by using the unique merits of radiology to combine his passions for clinical care, academic scholarship, and industrial innovation. Most importantly, he plans to dedicate his career to increasing access to state-of-the-art healthcare, so that the advancements of his classmates and colleagues can one day be available to the patients in his hometown. -
Hoang Minh Hieu Nguyen
MD Student, expected graduation Spring 2030
BioHoang Minh Hieu Nguyen, from Di Linh, Vietnam, is pursuing an MD at Stanford School of Medicine. They earned a bachelor’s degree in neuroscience from Middlebury College and a master of philosophy in clinical neurosciences from the University of Cambridge. Hieu aspires to combine science, the arts, and entrepreneurship to improve healthcare quality and access for global populations burdened by chronic disease. Hieu has contributed to advancing our understanding of cancer and neurodegenerative diseases through research at Middlebury College, Rockefeller University, Memorial Sloan Kettering Cancer Center, University of Cambridge, and Dana-Farber Cancer Institute. As a Social Entrepreneurship Fellow at Middlebury, they collaborated with the Kenyan Ministry of Health and the World Telehealth Initiative to establish Kenya’s first telemedicine system. This program provides lifesaving services, including dialysis, to Longisa, where such services were once unreachable.
-
Judy Nguyen, MD
Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine
BioI am originally from San Diego, California where I attended medical school and did a surgical internship at UCSD. While there, I was exposed to the field of Nuclear Medicine and became fascinated by molecular imaging and the burgeoning field of theragnostics. I chose the Nuclear Medicine residency program at Stanford because it is one of the premier molecular imaging programs in the world, where some of the best known physicians and scientists in the field are located. Situated in Silicon Valley and rooted in a culture of collaboration, Stanford reaps the benefits from being at the intersection of technology, innovation, engineering and science to produce ground breaking research that continually pushes the imagination and limits of Nuclear Medicine. I am honored to be able to pursue my clinical interests and further my career in this environment.
-
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
